This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Institut Mondor de Recherche Biomédicale | |
|---|---|
| Name | Institut Mondor de Recherche Biomédicale |
| Established | 1960s |
| Type | Biomedical research institute |
| Location | Créteil, Val-de-Marne, Île-de-France, France |
| Affiliations | Université Paris-Est Créteil, Assistance Publique–Hôpitaux de Paris |
Institut Mondor de Recherche Biomédicale is a major biomedical research center located in Créteil, Val-de-Marne, Île-de-France, France. The institute integrates basic, translational, and clinical research with regional hospitals and universities, contributing to national and European biomedical initiatives. It hosts multidisciplinary teams focused on immunology, virology, oncology, cardiology, and metabolic diseases, and participates in public health responses, clinical trials, and graduate education.
The institute traces its origins to mid-20th century expansions of hospital-associated research in France, aligning with reforms that affected Assistance Publique–Hôpitaux de Paris, Université Paris-Est Créteil, and regional health planning in Île-de-France. Its development intersected with national programs led by the Inserm and collaborations with institutions such as CNRS and Collège de France. Throughout the late 20th and early 21st centuries the institute engaged with European frameworks including the Horizon 2020 program and cooperative networks involving Institut Pasteur, Institut Curie, and CEA. Major episodes included growth during public health crises that connected the institute to emergency responses coordinated with Ministry of Solidarity and Health (France) and international partners like World Health Organization initiatives.
Governance is organized through a board that includes representatives from Assistance Publique–Hôpitaux de Paris, Université Paris-Est Créteil, and national research agencies such as Inserm and CNRS. Executive leadership coordinates strategy with clinical directors from affiliated hospitals including Hôpital Henri-Mondor and administrative stakeholders linked to regional authorities in Val-de-Marne. The institute operates within French legal frameworks alongside oversight from bodies like the Agence nationale de sécurité du médicament et des produits de santé and participates in ethical review processes comparable to those at Comité consultatif national d'éthique.
Research units span basic to applied domains and are organized into thematic departments: immunology and infectious diseases, oncology and hematology, cardiovascular biology, metabolism and endocrinology, neuroscience, and molecular genetics. Teams have formal links with units from Inserm Unit partners, CNRS laboratories, and hospital clinical departments at Hôpital Henri-Mondor. Projects frequently involve collaborations with Institut Pasteur, Institut Curie, CEA, AP-HP research networks, and European consortia associated with European Research Council grants and European Molecular Biology Laboratory collaborations.
Clinical programs couple bench science with patient care through translational platforms that support clinical trials, biobanking, and precision medicine initiatives. The institute works with oncology groups such as Gustave Roussy networks and cardiovascular trial consortia linked to European Society of Cardiology. It participates in multicenter studies coordinated with Agence de la biomédecine, national cancer grids like Organisation Nationale des Cancers, and international trial sponsors including collaborations with institutions such as NIH and European Medicines Agency. Translational efforts address vaccine development, antiviral therapeutics, targeted oncology agents, and metabolic interventions.
The institute is a training hub for graduate students, postdoctoral fellows, and clinician-scientists through partnerships with Université Paris-Est Créteil, doctoral schools affiliated with Sorbonne Université, and professional programs connected to Assistance Publique–Hôpitaux de Paris. It hosts doctoral research projects funded by bodies like ANR and fellowships linked to programs from Marie Skłodowska-Curie Actions and European Research Council. Continuing medical education activities are offered in conjunction with hospital partners, national specialty societies such as Société Française d'Oncologie Médicale, and international organizations including European Academy of Neurology.
The institute maintains formal and informal partnerships with national agencies Inserm, CNRS, and Ministry of Higher Education, Research and Innovation (France), as well as international institutions including Institut Pasteur, Institut Curie, CEA, Harvard Medical School, and European university hospitals. It engages in consortia funded by Horizon Europe and bilateral collaborations with centers such as Karolinska Institutet, University College London, and Max Planck Society institutes. Industry collaborations include joint projects with pharmaceutical and biotechnology firms operating in the Paris region and broader European markets, often mediated by technology transfer offices and incubators affiliated with BPI France.
Facilities include wet laboratories, biosafety level platforms, animal facilities accredited under French regulations, high-throughput genomics and proteomics cores linked to regional platforms such as those at Institut Pasteur and CEA, and clinical research units embedded within Hôpital Henri-Mondor and partner hospitals. The institute houses biobanks compliant with standards promoted by BBMRI-ERIC and data platforms aligned with European Open Science Cloud principles. Shared resources support imaging modalities similar to those at Institut Curie and computational infrastructures interfacing with national supercomputing resources and initiatives such as France Life Imaging.
Category:Research institutes in France Category:Medical research institutes